What type of study is this?

This is a Experimental Study study (also classified as: Animal Study).

September 27, 2025ChannelsOpen Access

Inhibition of lipolysis in visceral adipose tissue from obese mice and humans prevents impairment of endothelial Kir2.1 channels

View Full Paper

Ask AI

Bookmark

Inhibiting lipolysis in visceral adipose tissue prevents endothelial dysfunction by preserving Kir2.1 function.
Palmitic acid treatment inhibited Kir2.1 channels in endothelial cells, implicating fatty acids in dysfunction.
VAT was pretreated with inhibitors, suggesting that lipolysis plays a critical role in Kir2.1 impairment.
Findings highlight VAT-derived fatty acids as paracrine mediators in endothelial dysfunction among obese individuals.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This research demonstrates the role of visceral adipose tissue lipolysis in impairing Kir2.1 channels in obesity, indicating potential therapeutic avenues.

Cite This Study

Hudgins et al. (2025) studied this question.

synapsesocial.com/papers/68d7e84439bbb06045426b45 https://doi.org/10.1080/19336950.2025.2564651

View Full Paper

Ask AI

Bookmark

Implication

This research demonstrates the role of visceral adipose tissue lipolysis in impairing Kir2.1 channels in obesity, indicating potential therapeutic avenues.

Inhibition of lipolysis in visceral adipose tissue from obese mice and humans prevents impairment of endothelial Kir2.1 channels

Key Points

Discussion

Implication

Cite This Study

Inhibition of lipolysis in visceral adipose tissue from obese mice and humans prevents impairment of endothelial Kir2.1 channels

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider